Teleflex (NYSE:TFX) Releases FY 2026 Earnings Guidance

Teleflex (NYSE:TFX) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 6.250-6.550 for the period, compared to the consensus EPS estimate of 15.180. The company issued revenue guidance of $2.3 billion-$2.3 billion, compared to the consensus revenue estimate of $3.7 billion.

Teleflex Stock Down 0.3%

Shares of NYSE TFX opened at $111.83 on Thursday. The company has a market cap of $4.94 billion, a price-to-earnings ratio of -15.21, a PEG ratio of 1.46 and a beta of 0.92. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. Teleflex has a 12 month low of $100.18 and a 12 month high of $178.79. The stock has a 50-day moving average price of $111.44 and a two-hundred day moving average price of $118.67.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Truist Financial increased their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 target price on shares of Teleflex in a report on Wednesday, December 17th. Wells Fargo & Company cut their price target on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a report on Thursday, January 29th. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Finally, Needham & Company LLC raised Teleflex from a “hold” rating to a “buy” rating and set a $138.00 target price for the company in a research report on Tuesday, January 27th. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Teleflex has an average rating of “Hold” and an average target price of $139.00.

Institutional Investors Weigh In On Teleflex

Institutional investors and hedge funds have recently made changes to their positions in the business. UMB Bank n.a. increased its holdings in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares in the last quarter. Maryland State Retirement & Pension System grew its stake in shares of Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock worth $1,056,000 after acquiring an additional 129 shares in the last quarter. Osaic Holdings Inc. raised its holdings in shares of Teleflex by 17.5% in the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock valued at $148,000 after purchasing an additional 186 shares during the last quarter. Vident Advisory LLC lifted its position in shares of Teleflex by 2.8% during the fourth quarter. Vident Advisory LLC now owns 6,992 shares of the medical technology company’s stock valued at $853,000 after purchasing an additional 188 shares in the last quarter. Finally, Empowered Funds LLC boosted its holdings in Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.